As of Feb 27
| -0.93 / -5.14%|
The 5 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 24.00, with a high estimate of 27.00 and a low estimate of 21.00. The median estimate represents a +39.70% increase from the last price of 17.18.
The current consensus among 7 polled investment analysts is to Buy stock in NxStage Medical Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.